{"id":516198,"date":"2021-07-22T07:03:53","date_gmt":"2021-07-22T11:03:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/"},"modified":"2021-07-22T07:03:53","modified_gmt":"2021-07-22T11:03:53","slug":"igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/","title":{"rendered":"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC"},"content":{"rendered":"

<\/p>\n

IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease <\/b>Using THC<\/b><\/p>\n

POTOMAC, Md.–(BUSINESS WIRE<\/a>)–
\nIndia Globalization Capital, Inc. (the \u201cCompany\u201d) (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office (\u201cUSPTO\u201d) issued a patent (#11,065,225) for the treatment of Alzheimer\u2019s disease entitled \u201cUltra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimer\u2019s Disease.\u201d\n<\/p>\n

\nThe original patent application was initiated by the University of South Florida (\u201cUSF\u201d) and filed on August 1, 2016. On May 25, 2017, IGC entered into an exclusive license agreement with USF with respect to the patent application and the associated research conducted on Alzheimer\u2019s disease.\n<\/p>\n

\nThe granted patent relates to IGC\u2019s proprietary formulation intended to assist in the treatment of individuals living with Alzheimer\u2019s disease. IGC\u2019s proprietary formulation, IGC-AD1, is the subject of the Company\u2019s previously-disclosed Phase 1 clinical trial. The Company recently announced the completion of Cohort 3 in its placebo-controlled Multiple Ascending Dose (MAD) phase 1 trial for establishing safety and tolerability of IGC-AD1 that uses THC on patients suffering from Alzheimer\u2019s disease.\n<\/p>\n

Forward-looking Statements<\/b>:\n<\/p>\n

\nThis press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on IGC\u2019s expectations and are subject to several risks and uncertainties, certain of which are beyond IGC\u2019s control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company\u2019s failure or inability to commercialise one or more of the Company\u2019s products or technologies, including the investigational new drug or formulation described in this release, or failure to obtain FDA approval for the investigational new drug; testing results from human clinical trials that may not be favorable or as anticipated; general economic conditions that are less favorable than expected, including as a result of the ongoing COVID-19 pandemic; the FDA\u2019s general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC\u2019s SEC filings. IGC incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Report on Form 10-K filed with the SEC on June 14, 2021, as if fully incorporated and restated herein. Considering these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur.\n<\/p>\n

About IGC<\/b>:\n<\/p>\n

\nIndia Globalization Capital, Inc. (IGC) engages in the development of cannabinoid-based therapies for indications such as Alzheimer’s disease and pain. It operates in two lines of business, Infrastructure and Life Sciences and is headquartered in Potomac, MD.\n<\/p>\n

www.igcinc.us<\/a><\/span>, www.igcpharma.com<\/a><\/span>, Twitter @IGCIR.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210722005361\/en\/<\/a><\/span><\/p>\n

\nClaudia Grimaldi \/ 301-983-0998\n<\/p>\n

\n\u00a0\n<\/p>\n

KEYWORDS:<\/b> United States North America Maryland<\/p>\n

INDUSTRY KEYWORDS:<\/b> Alternative Medicine Health Other Health<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC POTOMAC, Md.–(BUSINESS WIRE)– India Globalization Capital, Inc. (the \u201cCompany\u201d) (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office (\u201cUSPTO\u201d) issued a patent (#11,065,225) for the treatment of Alzheimer\u2019s disease entitled \u201cUltra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimer\u2019s Disease.\u201d The original patent application was initiated by the University of South Florida (\u201cUSF\u201d) and filed on August 1, 2016. On May 25, 2017, IGC entered into an exclusive license agreement with USF with respect to the patent application and the associated research conducted on Alzheimer\u2019s disease. The granted patent relates to IGC\u2019s proprietary formulation intended to … <\/p>\n

Continue reading “IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-516198","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC POTOMAC, Md.–(BUSINESS WIRE)– India Globalization Capital, Inc. (the \u201cCompany\u201d) (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office (\u201cUSPTO\u201d) issued a patent (#11,065,225) for the treatment of Alzheimer\u2019s disease entitled \u201cUltra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimer\u2019s Disease.\u201d The original patent application was initiated by the University of South Florida (\u201cUSF\u201d) and filed on August 1, 2016. On May 25, 2017, IGC entered into an exclusive license agreement with USF with respect to the patent application and the associated research conducted on Alzheimer\u2019s disease. The granted patent relates to IGC\u2019s proprietary formulation intended to … Continue reading "IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-22T11:03:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC\",\"datePublished\":\"2021-07-22T11:03:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/\"},\"wordCount\":483,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/\",\"name\":\"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-07-22T11:03:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/","og_locale":"en_US","og_type":"article","og_title":"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC - Market Newsdesk","og_description":"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC POTOMAC, Md.–(BUSINESS WIRE)– India Globalization Capital, Inc. (the \u201cCompany\u201d) (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office (\u201cUSPTO\u201d) issued a patent (#11,065,225) for the treatment of Alzheimer\u2019s disease entitled \u201cUltra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimer\u2019s Disease.\u201d The original patent application was initiated by the University of South Florida (\u201cUSF\u201d) and filed on August 1, 2016. On May 25, 2017, IGC entered into an exclusive license agreement with USF with respect to the patent application and the associated research conducted on Alzheimer\u2019s disease. The granted patent relates to IGC\u2019s proprietary formulation intended to … Continue reading \"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-22T11:03:53+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC","datePublished":"2021-07-22T11:03:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/"},"wordCount":483,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/","name":"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-07-22T11:03:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210722005361r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/igc-announces-issuance-of-patent-for-the-treatment-of-alzheimers-disease-using-thc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IGC Announces Issuance of Patent for the Treatment of Alzheimer\u2019s Disease Using THC"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=516198"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516198\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=516198"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=516198"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=516198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}